Skip to main content

previous disabled Page of 24
and
  1. Article

    Open Access

    Correction: Systematic review of fatigue severity in ME/CFS patients: insights from randomized controlled trials

    Jae‑Woong Park, Byung‑** Park, **‑Seok Lee in Journal of Translational Medicine (2024)

  2. Article

    Open Access

    Systematic review of fatigue severity in ME/CFS patients: insights from randomized controlled trials

    Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating illness medically unexplained, affecting approximately 1% of the global population. Due to the subjective complaint, assessing the ...

    Jae-Woong Park, Byung-** Park, **-Seok Lee in Journal of Translational Medicine (2024)

  3. Article

    Open Access

    A scheme to underpin key mediator(s) in Salinosporamide(s) against pan-tumor via systems biology concept

    Ki-Kwang Oh, Sang-Jun Yoon, Seol Hee Song in Journal of Translational Medicine (2024)

  4. Article

    Open Access

    heredERA Breast Cancer: a phase III, randomized, open-label study evaluating the efficacy and safety of giredestrant plus the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with previously untreated HER2-positive, estrogen receptor-positive locally advanced or metastatic breast cancer

    HER2-positive, estrogen receptor-positive breast cancer (HER2+, ER+ BC) is a distinct disease subtype associated with inferior response to chemotherapy plus HER2-targeted therapy compared with HER2+, ER-negati...

    Sherko Kuemmel, Catherine Harper-Wynne, Yeon Hee Park, Fábio Franke in BMC Cancer (2024)

  5. Article

    Open Access

    Real-world efficacy and safety of capecitabine with oxaliplatin in patients with advanced adenocarcinoma of the ampulla of Vater

    Adenocarcinoma of the ampulla of Vater (AoV) is one of the rare periampullary cancers, and due to its anatomical location, it is categorized into various histologic subtypes. Its rarity and diversity pose chal...

    Seunghwan Lee, Se Jun Park, Kabsoo Shin, Tae Ho Hong, In-Ho Kim, Myung Ah Lee in BMC Cancer (2024)

  6. Article

    Open Access

    Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22–09

    Next-generation sequencing (NGS) has been introduced to many Korean institutions to support molecular diagnostics in cancer since 2017, when it became eligible for reimbursement by the National Health Insuranc...

    Sun Young Kim, Jee Hyun Kim, Tae-Yong Kim, Sook Ryun Park, Shinkyo Yoon in BMC Cancer (2024)

  7. Article

    Open Access

    Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis

    Peritoneal carcinomatosis (PC) is a complex manifestation of abdominal cancers, with a poor prognosis and limited treatment options. Recent work identifying high concentrations of the cytokine interleukin-6 (I...

    Neda Dadgar, Christopher Sherry, Jenna Zimmerman in Journal of Translational Medicine (2024)

  8. Article

    Open Access

    Integrated clinical and genomic models using machine-learning methods to predict the efficacy of paclitaxel-based chemotherapy in patients with advanced gastric cancer

    Paclitaxel is commonly used as a second-line therapy for advanced gastric cancer (AGC). The decision to proceed with second-line chemotherapy and select an appropriate regimen is critical for vulnerable patien...

    Yonghwa Choi, Jangwoo Lee, Keewon Shin, Ji Won Lee, Ju Won Kim, Soohyeon Lee in BMC Cancer (2024)

  9. Article

    Open Access

    MicroRNA-21a-5p inhibition alleviates systemic sclerosis by targeting STAT3 signaling

    MicroRNA (miRNA)-21-5p participates in various biological processes, including cancer and autoimmune diseases. However, its role in the development of fibrosis in the in vivo model of systemic sclerosis (SSc) ...

    **-Sil Park, Chongtae Kim, JeongWon Choi in Journal of Translational Medicine (2024)

  10. Article

    Open Access

    mFOLFIRINOX versus mFOLFOX 6 as adjuvant treatment for high-risk stage III colon cancer - the FROST trial: study protocol for a multicenter, randomized controlled, phase II trial

    High-risk stage III colon cancer has a considerably poorer prognosis than stage II and low-risk stage III colon cancers. Nevertheless, most guidelines recommend similar adjuvant treatment approaches for all th...

    Kyung-Ha Lee, In Jun Yang, Gi Won Ha, Jaeim Lee, Youn Young Park in BMC Cancer (2024)

  11. Article

    Open Access

    Transgelin-2, a novel cancer stem cell-related biomarker, is a diagnostic and therapeutic target for biliary tract cancer

    Biliary tract cancer (BTC) is a relatively rare but aggressive gastrointestinal cancer with a high mortality rate. Cancer stem cell (CSC) populations play crucial roles in tumor biology and are responsible for...

    Jung Hyun Jo, Soo Been Park, Joowon Chung, Taeyun Oh, Hee Seung Lee in BMC Cancer (2024)

  12. Article

    Open Access

    The epitome of tailor-made short positively charged peptides against HCC via integrated pharmacology

    Ki-Kwang Oh, Jung-A Eom, Kyeong ** Lee, Goo-Hyun Kwon in Journal of Translational Medicine (2024)

  13. Article

    Open Access

    Keratinocyte-derived circulating microRNAs in extracellular vesicles: a novel biomarker of psoriasis severity and potential therapeutic target

    Psoriasis is a chronic inflammatory disorder characterized by pathogenic hyperproliferation of keratinocytes and immune dysregulation. Currently, objective evaluation tools reflecting the severity of psoriasis...

    Young Joon Park, Dong Chan Kim, Soo-** Lee in Journal of Translational Medicine (2024)

  14. Article

    Open Access

    Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06)

    Immune checkpoint inhibitor (ICI) or irinotecan-based chemotherapy is frequently used after failure of second-line paclitaxel plus ramucirumab treatment for patients with locally advanced unresectable or metas...

    Sung Hee Lim, Keun-Wook Lee, Jae-Joon Kim, Hyeon-Su Im, In-Ho Kim in BMC Cancer (2024)

  15. Article

    Open Access

    Comparison of partitioned survival modeling with state transition modeling approaches with or without consideration of brain metastasis: a case study of Osimertinib versus pemetrexed-platinum

    The partitioned survival model (PSM) and the state transition model (STM) are widely used in cost-effectiveness analyses of anticancer drugs. Using different modeling approaches with or without consideration o...

    Yoon-Bo Shim, Byeong-Chan Oh, Eui-Kyung Lee, Mi-Hai Park in BMC Cancer (2024)

  16. Article

    Open Access

    Central 5-HTergic hyperactivity induces myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-like pathophysiology

    Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a significant medical challenge, with no indisputable pathophysiological mechanism identified to date.

    **-Seok Lee, Ji-Yun Kang, Samuel-Young Park in Journal of Translational Medicine (2024)

  17. Article

    Open Access

    Phenylpropanoid-enriched broccoli seedling extract can reduce inflammatory markers and pain behavior

    Pain is a worldwide problem requiring an effective, affordable, non-addictive therapy. Using the edible plant broccoli, a growth protocol was developed to induce a concentrated combinatorial of potential anti-...

    Aleksandra A. Gurgul, Yahya Najjar, Ana Chee in Journal of Translational Medicine (2023)

  18. Article

    Open Access

    PSMD1 as a prognostic marker and potential target in oropharyngeal cancer

    Despite the diverse genetic mutations in head and neck cancer, the chemotherapy outcome for this cancer has not improved for decades. It is urgent to select prognostic factors and therapeutic targets for oroph...

    Hae Chan Park, Hyo** Kim, Ji-Yeong Kim, Hye-Yeon Lee, **yi Lee, WonJae Cha in BMC Cancer (2023)

  19. Article

    Open Access

    A differential diagnosis between uterine leiomyoma and leiomyosarcoma using transcriptome analysis

    The objective of this study was to estimate the accuracy of transcriptome-based classifier in differential diagnosis of uterine leiomyoma and leiomyosarcoma. We manually selected 114 normal uterine tissue and ...

    Kidong Kim, Sarah Kim, Tae** Ahn, Hyo** Kim, So-** Shin, Chel Hun Choi in BMC Cancer (2023)

  20. Article

    Open Access

    Refining gastric cancer staging: examining the interplay between number and anatomical location of metastatic lymph nodes - a retrospective multi-institutional study

    The current gastric cancer staging system relies on the number of metastatic lymph nodes (MLNs) for nodal stage determination. However, incorporating additional information such as topographic status may help ...

    Chul-Hyo Jeon, Ki Bum Park, Hayemin Lee, Dong ** Kim, Ho Seok Seo in BMC Cancer (2023)

previous disabled Page of 24